Global Preterm Birth And PROM Testing Market Report By Test Type (Pelvic exam, Ultrasound, Biochemical Markers, Uterine Monitoring, Nitazine Test, Ferning Test, Pooling, PAMG-1 Immunoassay, IGFBP Test, Fetal Fibronectin (FFN), Others) By Application (PROM, Preterm Labor, Chorioamnionitis) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2023-2032

The global demand for Preterm Birth And PROM Testing Market is presumed to reach the market size of nearly USD 3.34 Billion by 2032 from USD 1.5 Billion in 2023 with a CAGR of 9.3% under the study period 2024 - 2032.
 
Preterm birth and PROM testing are done for premature birth and premature rupture of the membrane. These are the conditions where the baby takes birth in 37 weeks instead of completing 40 weeks which is considered normal. In addition to this, premature rupture of the membrane happens in PROM before the onset of labor. 
 
Market Dynamics
 
The increasing number of preterm births due to the rising average number of women being pregnant is primarily driving the market growth. The rising various health issues such as diabetes and high blood pressure among women is also fuelling the demand for preterm birth and PROM testing. However, the availability of alternative diagnostic options such as ultrasound, transvaginal scan, uterine monitoring, and lab tests are likely to hamper the market growth. Whereas, rising awareness about product offerings for preterm birth and PROM testing is expected to create potential demand over the forecast period.
 
The report covers Porter's Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level.
 
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of preterm birth and PROM testing.
 
Market Segmentation
 
The entire preterm birth and PROM testing market has been sub-categorized into test type and end-user. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
 

By Test Type 

• Pelvic Exam 
• Ultrasound 
• Biochemical Markers (Interleukin (IL)-6, C-Reactive Protein (CRP), IL-1, IL-2, IL-8, TNF-a, Corticotropin-Releasing Hormone (CRH), Alpha-fetoprotein (AFP))
• Uterine Monitoring 
• Nitazine Test 
• Ferning Test 
• Pooling 
• PAMG-1 Immunoassay 
• IGFBP Test 
• Fetal Fibronectin (FFN) 
• Others 

By Application 

• PROM 
• Preterm Labor 
• Chorioamnionitis

 
Regional Analysis
 
This section covers regional segmentation which accentuates on current and future demand for preterm birth and PROM testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
 
Global Preterm Birth And PROM Testing Market Share by Region (Representative Graph)
 

 
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the preterm birth and PROM testing market include Qiagen N.V., Hologic Inc., Cooper Surgical Inc., Abbott, Medixbiochemica, Sera prognostics, Clinical Innovations LLC, Biosynex, NX Prenatal Inc., IQ Products. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.